Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration

[1]  Changhan Lee,et al.  Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence , 2017, Molecular and Cellular Endocrinology.

[2]  J. Powell,et al.  Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation , 2017, The Journal of Immunology.

[3]  F. Issa.  Foxp3 and Toll-Like Receptor Signaling Balance Treg Cell Anabolic Metabolism for Suppression , 2017 .

[4]  Cody S. Olsen,et al.  Distinct effects of obesity and puberty on risk and age at onset of pediatric MS , 2016, Annals of clinical and translational neurology.

[5]  M. Warmoes,et al.  Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression , 2016, Nature Immunology.

[6]  T. Morgan,et al.  A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. , 2016, Cell reports.

[7]  T. Olsson,et al.  Body mass index during adolescence, rather than childhood, is critical in determining MS risk , 2016, Multiple sclerosis.

[8]  N. Timpson,et al.  Obesity and Multiple Sclerosis: A Mendelian Randomization Study , 2016, PLoS medicine.

[9]  J. Correale,et al.  Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis. , 2016, JAMA neurology.

[10]  Li Guo,et al.  Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice , 2016, Journal of Neuroimmunology.

[11]  V. De Rosa,et al.  Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens , 2016, Clinical and experimental immunology.

[12]  F. Carbone,et al.  The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements , 2016, Immunity.

[13]  E. Havrdová,et al.  The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus. , 2015, Neuro endocrinology letters.

[14]  V. De Rosa,et al.  Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants , 2015, Nature Immunology.

[15]  G. Tedeschi,et al.  Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. , 2015, Metabolism: clinical and experimental.

[16]  G. Trianni,et al.  Bioenergetics profile of CD4(+) T cells in relapsing remitting multiple sclerosis subjects. , 2015, Journal of biotechnology.

[17]  T. Olsson,et al.  Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis , 2014, Neurology.

[18]  F. Carbone,et al.  Corrigendum: Regulatory T cell proliferative potential is impaired in human autoimmune disease , 2014, Nature Medicine.

[19]  L. Platanias,et al.  Beta Interferon Regulation of Glucose Metabolism Is PI3K/Akt Dependent and Important for Antiviral Activity against Coxsackievirus B3 , 2014, Journal of Virology.

[20]  Chih-Hao Chang,et al.  Fueling Immunity: Insights into Metabolism and Lymphocyte Function , 2013, Science.

[21]  C. Weyand,et al.  Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells , 2013, The Journal of experimental medicine.

[22]  Å. Lernmark,et al.  Meta-Immunological Profiling of Children With Type 1 Diabetes Identifies New Biomarkers to Monitor Disease Progression , 2013, Diabetes.

[23]  J. Michálek,et al.  Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations , 2012, Journal of the Neurological Sciences.

[24]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[25]  M. Salmon,et al.  The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. , 2008, The Journal of clinical investigation.

[26]  C. Baecher-Allan,et al.  Multiple Sclerosis and Regulatory T Cells , 2008, Journal of Clinical Immunology.

[27]  J. Arbiser,et al.  Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis1 , 2007, The Journal of Immunology.

[28]  C. Markowitz.  Interferon-beta , 2007, Neurology.

[29]  Y. Okuda,et al.  The activation of memory CD4+ T cells and CD8+ T cells in patients with multiple sclerosis , 2005, Journal of the Neurological Sciences.

[30]  V. De Rosa,et al.  Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Hofbauer,et al.  Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid , 2004, Acta Neuropathologica.

[32]  J. Kratzsch,et al.  The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data , 2003, International Journal of Obesity.

[33]  C. Brosnan,et al.  Peroxisome proliferator‐activated receptor‐γ agonists prevent experimental autoimmune encephalomyelitis , 2002 .

[34]  S. Cummings,et al.  Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[35]  J. Hillert,et al.  Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis , 2000, Multiple sclerosis.

[36]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[37]  A. Aruffo,et al.  CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Akbar,et al.  Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. , 2006, The Journal of clinical investigation.

[39]  C. Brosnan,et al.  Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. , 2002, Annals of neurology.

[40]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.